NASDAQ:FONR FONAR (FONR) Stock Forecast, Price & News $17.66 -0.10 (-0.56%) (As of 06/9/2023 ET) Add Compare Share Share Today's Range$17.50▼$17.8050-Day Range$15.27▼$17.7652-Week Range$13.28▼$19.00Volume6,711 shsAverage Volume9,346 shsMarket Capitalization$115.50 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media About FONAR (NASDAQ:FONR) StockFONAR Corp. engages in the design, manufacture, sale, and servicing of magnetic resonance imaging scanners. It operates through the Manufacturing and Servicing of Medical Equipment and Management of Diagnostic Imaging Center segments. The Manufacturing and Servicing of Medical Equipment segment promotes its product, Fonar Upright MRI. The Management of Diagnostic Imaging Center segment offers management, administrative, billing and collection services, office space, equipment, repair, maintenance service and clerical, and non-medical personnel to medical providers through its subsidiary, Health Management Corp. of America. The company was founded by Raymond V. Damadian on July 17, 1978 and is headquartered in Melville, NY.Read More Receive FONR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for FONAR and its competitors with MarketBeat's FREE daily newsletter. Email Address FONR Stock News HeadlinesJune 10, 2023 | americanbankingnews.comAnalyzing Positron (OTCMKTS:POSC) and FONAR (NASDAQ:FONR)June 7, 2023 | finance.yahoo.comFONAR Corporation's (NASDAQ:FONR) top owners are retail investors with 49% stake, while 46% is held by institutionsJune 10, 2023 | Behind the Markets (Ad)The single greatest medical breakthrough of all time?We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.May 23, 2023 | americanbankingnews.comFONAR (NASDAQ:FONR) Lifted to "Strong-Buy" at StockNews.comMay 15, 2023 | finanznachrichten.deFonar Corporation: Fonar Announces Financial Results for Fiscal 2023 3rd Quarter and Nine-Month PeriodMay 15, 2023 | finance.yahoo.comFonar Announces Financial Results for Fiscal 2023 3rd Quarter and Nine-Month PeriodMay 13, 2023 | americanbankingnews.comStockNews.com Downgrades FONAR (NASDAQ:FONR) to BuyApril 23, 2023 | finance.yahoo.comInvestors in FONAR (NASDAQ:FONR) have unfortunately lost 43% over the last five yearsJune 10, 2023 | Behind the Markets (Ad)The single greatest medical breakthrough of all time?We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.March 28, 2023 | finance.yahoo.comGreat news for FONAR Corporation (NASDAQ:FONR): Insiders acquired stock in large numbers last yearMarch 22, 2023 | americanbankingnews.comFONAR (NASDAQ:FONR) vs. CONMED (NASDAQ:CNMD) Critical ComparisonFebruary 5, 2023 | finance.yahoo.comFONAR (NASDAQ:FONR) Could Be Struggling To Allocate CapitalDecember 29, 2022 | finance.yahoo.comWhile institutions own 39% of FONAR Corporation (NASDAQ:FONR), individual investors are its largest shareholders with 50% ownershipNovember 30, 2022 | finance.yahoo.comFonar Corporation Designates Laurel Hill Advisory Group, LLC as Information Agent for the Company's $9 Million Share Repurchase ProgramNovember 17, 2022 | finance.yahoo.comFONAR Reports First Quarter 2023 EarningsNovember 14, 2022 | finance.yahoo.comInvestors in FONAR (NASDAQ:FONR) have unfortunately lost 23% over the last five yearsOctober 25, 2022 | nasdaq.comFonar Corporation Common Stock (FONR)October 24, 2022 | reuters.comFONR.A - Fonar Corporation | Stock Price & Latest News | ReutersOctober 19, 2022 | finance.yahoo.comQuite a few insiders invested in FONAR Corporation (NASDAQ:FONR) last year which is positive news for shareholdersOctober 17, 2022 | streetinsider.comStatera Biopharma Announces Signing of a Binding MOU with Holobeam Technologies to Gain Access to Holobeam's Disruptive Diagnostic Imaging and Therapeutic Technology for Cancer Patients - StreetInsider.comOctober 17, 2022 | streetinsider.comStatera Biopharma (STAB) Announces Signing of a Binding MOU with Holobeam Technologies to Gain Access to Holobeam's Disruptive Diagnostic Imaging and Therapeutic Technology for Cancer Patients - StreetInsider.comOctober 13, 2022 | globenewswire.comGlobal MR Imaging in Neurosurgery Market Analysis Report 2021-2031: Opportunities in the Development of Cost-Effective Robotic-Assisted MRI Systems and MRI-Compatible Robotic Systems - GlobeNewswireOctober 7, 2022 | benzinga.comMRI System Market Expected to Increase 1.7x During 2022-2030 | Soaring Prevalence of Chronic Diseases Pri - BenzingaOctober 6, 2022 | nasdaq.comA Look At The Intrinsic Value Of FONAR Corporation (NASDAQ:FONR) - NasdaqOctober 6, 2022 | nasdaq.comA Look At The Intrinsic Value Of FONAR Corporation (NASDAQ:FONR)October 5, 2022 | finance.yahoo.comEstimating The Fair Value Of FONAR Corporation (NASDAQ:FONR)September 28, 2022 | marketscreener.comFONAR CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION. (form 10-K) - Marketscreener.comSee More Headlines FONR Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart FONR Company Calendar Last Earnings5/11/2020Today6/10/2023Fiscal Year End6/30/2023Next Earnings (Estimated)8/21/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:FONR CUSIPN/A CIK355019 Webwww.fonar.com Phone(631) 694-2929Fax631-753-5150Employees495Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$12.44 million Net Margins10.63% Pretax Margin17.11% Return on Equity7.97% Return on Assets5.94% Debt Debt-to-Equity Ratio0.01 Current Ratio8.76 Quick Ratio8.57 Sales & Book Value Annual Sales$97.59 million Price / Sales1.18 Cash Flow$3.91 per share Price / Cash Flow4.52 Book Value$22.31 per share Price / Book0.79Miscellaneous Outstanding Shares6,540,000Free Float5,977,000Market Cap$115.50 million OptionableNot Optionable Beta0.91 Key ExecutivesTimothy R. DamadianChairman, President & Chief Executive OfficerLuciano BonanniChief Operating Officer & Executive Vice PresidentClaudette J. V. ChanSecretary & DirectorDaniel CulverCommunications DirectorKey CompetitorsViewRayNASDAQ:VRAYHyperfineNASDAQ:HYPRBioSig TechnologiesNASDAQ:BSGMVivani MedicalNASDAQ:VANIMovanoNASDAQ:MOVEView All CompetitorsInsiders & InstitutionsKayne Anderson Rudnick Investment Management LLCBought 3,869 shares on 5/16/2023Ownership: 9.691%RBF Capital LLCSold 3,372 shares on 5/16/2023Ownership: 1.117%BlackRock Inc.Bought 1,002 shares on 5/12/2023Ownership: 1.510%O Shaughnessy Asset Management LLCSold 2,588 shares on 5/12/2023Ownership: 0.271%UBS Group AGBought 1,544 shares on 5/12/2023Ownership: 0.024%View All Insider TransactionsView All Institutional Transactions FONR Stock - Frequently Asked Questions How have FONR shares performed in 2023? FONAR's stock was trading at $16.75 at the beginning of 2023. Since then, FONR shares have increased by 5.4% and is now trading at $17.66. View the best growth stocks for 2023 here. When is FONAR's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 21st 2023. View our FONR earnings forecast. How were FONAR's earnings last quarter? FONAR Co. (NASDAQ:FONR) posted its earnings results on Monday, May, 11th. The medical equipment provider reported $0.18 earnings per share for the quarter. The medical equipment provider earned $21.69 million during the quarter. FONAR had a net margin of 10.63% and a trailing twelve-month return on equity of 7.97%. What other stocks do shareholders of FONAR own? Based on aggregate information from My MarketBeat watchlists, some companies that other FONAR investors own include Gilead Sciences (GILD), Amarin (AMRN), CRISPR Therapeutics (CRSP), Exelixis (EXEL), Pfizer (PFE), Bausch Health Companies (BHC), Incyte (INCY), Jazz Pharmaceuticals (JAZZ), Lannett (LCI) and Madrigal Pharmaceuticals (MDGL). What is FONAR's stock symbol? FONAR trades on the NASDAQ under the ticker symbol "FONR." Who are FONAR's major shareholders? FONAR's stock is owned by many different retail and institutional investors. Top institutional investors include Kayne Anderson Rudnick Investment Management LLC (9.69%), Dimensional Fund Advisors LP (6.24%), Renaissance Technologies LLC (5.03%), Money Concepts Capital Corp (4.63%), LSV Asset Management (2.24%) and BlackRock Inc. (1.51%). Insiders that own company stock include Luciano B Bonanni and Timothy Raymond Damadian. View institutional ownership trends. How do I buy shares of FONAR? Shares of FONR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is FONAR's stock price today? One share of FONR stock can currently be purchased for approximately $17.66. How much money does FONAR make? FONAR (NASDAQ:FONR) has a market capitalization of $115.50 million and generates $97.59 million in revenue each year. How many employees does FONAR have? The company employs 495 workers across the globe. How can I contact FONAR? FONAR's mailing address is 110 Marcus Drive, Melville NY, 11747. The official website for the company is www.fonar.com. The medical equipment provider can be reached via phone at (631) 694-2929, via email at investor@fonar.com, or via fax at 631-753-5150. This page (NASDAQ:FONR) was last updated on 6/10/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FONAR Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.